Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

China Fall Weighs Down Markets
Thu, 7 Jan 11:30 am

After opening the day deep in the red, the Indian indices continued to trade negatively. Sectoral indices are trading on a discouraging note with stocks from the auto, realty, and capital goods sectors witnessing maximum selling pressure.

The BSE Sensex is trading down 404 points (down 1.6%) and the NSE Nifty is trading down 123 points (down 1.6%). The BSE Mid Cap index is trading lower by 1.9% and the BSE Small Cap index is trading down by 2.2%. The rupee is trading at 66.89 to the US$.

Stocks in the automobile space are trading on a discouraging note with Maruti Suzuki and Tata Motors bearing the maximum brunt. As per a leading financial daily, Mahindra & Mahindra (M&M) has launched a premium pickup Imperio that sports SUV looks and superior performance with car like comforts. It comes at a starting price of Rs 6.25 lakhs (ex showroom), and will be available across Mahindra dealerships throughout India.

The Imperio will be available in four variants of two single cabin options and two double cabin options. The company regarding this launch said that it will lay a strong foundation for the new generation of pickups and will consolidate the company's presence in the SCV (small commercial vehicle) segment.

This launch can said to be the company's efforts to ramp up its growth in utility vehicles (UV) space. As Radhika Pandit, Managing Editor, ValuePro had pointed out in our result analysis report of the company, "Although the growth of UVs has been slow, the company expects the scenario to improve going forward backed by new product launches." To know more, read the entire report here (subscription required). The scrip of M&M is trading down by around 3.4%.

Pharma stocks are also trading in the red with Panacea Biotech and Glenmark Pharma leading the losses. As per an economic daily, Glenmark Pharmaceuticals has received tentative approval by the United States Food & Drug Administration (USFDA) for its Dronedarone tablets, 400 mg. The tablets are the generic version of Multaq Tablets, 400 mg of Sanofi-Aventis US LLC. The same are used to treat certain heart rhythm disorders.

Glenmark said that it expects to be eligible for 180 days of generic drug exclusivity upon final FDA approval. Furthermore, the company remains involved in a patent litigation in the US District Court for the District of Delaware, wherein Sanofi and Sanofi-Aventis US LLC have asserted its patents.

Tentative approval means that FDA has concluded that a drug product has met all required quality, safety and efficacy standards, but is not eligible for marketing in the US because of existing patent protections or exclusivities.

Glenmark's current portfolio consists of 104 products authorized for distribution in the US marketplace and 62 ANDA's pending approval with the USFDA. The stock of Glenmark Pharma is trading down by 3.5% on the BSE.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "China Fall Weighs Down Markets". Click here!

  

Views on News

BSE Sensex Surges 1,060 Points; TATA STEEL Among Top Gainers (Market Updates)

Mar 3, 2021 | Updated on Mar 3, 2021

The BSE Sensex Surged 1,060 Points; TATA STEEL Among Top Gainers. Find the latest update, special reports and news on all time high gainers of BSE Sensex at equitymaster.com.

Dollar at 80? (Fast Profits Daily)

Mar 3, 2021

Can the rupee depreciate to 80 against the US dollar? In this video, I'll show you what the charts say.

Motilal Oswal Asset Allocation Passive Fund of Fund: Aims to Benefit from Investing in Multi-Asset Passive Funds (Outside View)

Mar 3, 2021

PersonalFN analyses the features of Motilal Oswal Asset Allocation Passive Fund of Fund and explains the potential this fund has to offer to its investors.

Smallcap Investing in the New Normal World (Profit Hunter)

Mar 3, 2021

Here's why I think there is more steam left in smallcaps.

Why Rising Bond Yields Spooked the Market (Fast Profits Daily)

Mar 2, 2021

The stock market has been worried about rising bond yields recently and for good reason. In this video, I'll tell you why.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Mar 3, 2021 (Close)

MARKET STATS